Insider Trading & Ownership - Martin Daniel C.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Martin Daniel C.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-16
Sale
2024-02-20
4:05 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
2,267$15.62$35,40594,018
(Direct)
View
2024-01-16
Sale
2024-01-18
4:15 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
1,624$14.47$23,49947,660
(Direct)
View
2023-12-13
Sale
2023-12-14
4:05 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
1,727$15.37$26,53949,284
(Direct)
View
2023-11-30
Sale
2023-12-01
4:05 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
17,801$12.57$223,75545,435
(Direct)
View
2023-10-30
Sale
2023-10-31
4:10 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
1,407$12.02$16,90962,884
(Direct)
View
2023-06-16
Sale
2023-06-21
4:05 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
1,238$14.4$17,82958,413
(Direct)
View
2023-02-16
Sale
2023-02-17
4:12 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
1,159$15.1$17,500102,981
(Direct)
View
2023-01-17
Sale
2023-01-19
4:05 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
1,603$21.24$34,05048,389
(Direct)
View
2022-06-16
Sale
2022-06-21
4:35 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
1,311$10.75$14,09349,521
(Direct)
View
2022-02-16
Sale
2022-02-18
5:01 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
1,146$9.05$10,37148,668
(Direct)
View
2020-01-22
Sale
2020-01-24
4:10 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
26,999$67.18$1,813,70980,001
(Direct)
View
2019-09-19
Sale
2019-09-23
4:03 pm
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
3,000$35.56$106,68817,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-15
Option Award
2024-02-20
4:05 pm
N/A
2034-02-14
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
48,625$094,018
(Direct)
View
2023-12-12
Option Award
2023-12-14
4:05 pm
N/A
N/A
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
5,576$049,284
(Direct)
View
2023-10-28
Option Award
2023-10-31
4:10 pm
N/A
N/A
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
5,576$062,884
(Direct)
View
2023-02-15
Option Award
2023-02-17
4:12 pm
N/A
2033-02-14
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
55,751$0102,981
(Direct)
View
2022-01-18
Option Award
2022-01-20
5:00 pm
N/A
2032-01-17
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
68,334$0104,481
(Direct)
View
2021-12-15
Option Award
2021-12-17
4:00 pm
N/A
2031-12-14
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
71,271$099,118
(Direct)
View

Ownership
2021-04-02
5:56 pm
N/A
N/A
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
0$0215,692
(Direct)
View
2020-01-22
Conversion
2020-01-24
4:10 pm
N/A
2028-09-17
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
26,999$080,001
(Direct)
View
2020-01-22
Exercise
2020-01-24
4:10 pm
N/A
N/A
Deciphera Pharmaceuticals Inc.DCPHMartin Daniel C.
Chief Commercial Officer
26,999$36.180,001
(Direct)
View